Predictive Technology Group Addresses Use of Mesenchymal Stem Cells in Treatment of Secondary Issues Related to Coronavirus

NEXT STORY
Inventiva announces completion of patient visits for its Phase IIb clinical study with lanifibranor in NASH
PREV STORY
Next Generation Sequencing (NGS) Market is Expected to Grow at a CAGR of 16.2% to Reach $10.35 Billion by 2025: Meticulous Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

American Gene Technologies Inc. (AGT) Demonstrates Rationale of its Genetic Approach toward developing a Functional Cure for HIV Infection

ROCKVILLE, Md., Oct. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (“AGT”), ...

author_avatar
NASDAQ Market News

Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

author_avatar
NASDAQ Market News

Protech Enters Florida With Accretive Acquisition of Mayhugh’s Medical Equipment

author_avatar
NASDAQ Market News